Franklin Biotech Disc-AdvFTDZX
13F holders, Q4 2025 (December 31)1holders
$172.41avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Franklin Biotech Disc-Adv (FTDZX) in their 13F filings. The largest holder was Coston, McIsaac & Partners ($20K).
- Company
- Franklin Biotech Disc-Adv
- CUSIP
- 354713398
- Latest filing quarter
- Q4 2025
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $20K |
| Exits | 0 | $0 |
Ownership 1 holders
| Coston, McIsaac & Partners | 0.00% | New | 116 | $20K |
"% of holder's portfolio" is FTDZX's weight in each manager's 13F, not the share of Franklin Biotech Disc-Adv the manager owns.